New cancer immunotherapy drugs rapidly reach patients after approval – EurekAlert (press release)
|
New cancer immunotherapy drugs rapidly reach patients after approval
EurekAlert (press release) The majority of patients eligible for cancer immunotherapy drugs known as checkpoint inhibitors received treatment within a few months of FDA approval, according to a new Yale-led study. The finding suggests that cancer immunotherapies are adopted at a … |
